<VariationArchive RecordType="classified" VariationID="31110" VariationName="NM_018699.3(PRDM5):c.946_1623del" VariationType="Deletion" Accession="VCV000031110" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-09-03" DateCreated="2018-06-07" MostRecentSubmission="2018-06-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="40067" VariationID="31110">
      <GeneList>
        <Gene Symbol="PRDM5" FullName="PR/SET domain 5" GeneID="11107" HGNC_ID="HGNC:9349" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>4q27</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="120684291" stop="120922726" display_start="120684291" display_stop="120922726" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="121615928" stop="121844012" display_start="121615928" display_stop="121844012" Strand="-" />
          </Location>
          <OMIM>614161</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_018699.3(PRDM5):c.946_1623del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>4q27</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>52.46-KB DEL</Name>
      </OtherNameList>
      <XRefList>
        <XRef Type="Allelic variant" ID="614161.0001" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="GenomicLocationNotEstablished">The presence of exons 1â€“8 and 15 and 16 was shown by PCR, but no genomic sequencing was given in PMID 21664999; the deleted region was defined by nullzygosity analysis for 34 adjacent SNPs within the autozygous region.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_018699.3(PRDM5):c.946_1623del AND Brittle cornea syndrome 2" Accession="RCV000024106" Version="5">
        <ClassifiedConditionList TraitSetID="7582">
          <ClassifiedCondition DB="MedGen" ID="C3280011">Brittle cornea syndrome 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-06-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2011-06-10" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-06-07" MostRecentSubmission="2018-06-07">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21664999</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26395458</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7582" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16485" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Brittle cornea syndrome 2</ElementValue>
                <XRef ID="Brittle+cornea+syndrome+2/7869" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013605" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BCS2</ElementValue>
                <XRef Type="MIM" ID="614170" DB="OMIM" />
              </Symbol>
              <XRef ID="90354" DB="Orphanet" />
              <XRef ID="C3280011" DB="MedGen" />
              <XRef ID="MONDO:0013605" DB="MONDO" />
              <XRef Type="MIM" ID="614170" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="50653" SubmissionDate="2018-06-04" DateLastUpdated="2018-06-07" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="614161.0001_BRITTLE CORNEA SYNDROME 2" title="PRDM5, 52.46-KB DEL_BRITTLE CORNEA SYNDROME 2" />
        <ClinVarAccession Accession="SCV000045397" DateUpdated="2018-06-07" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-06-10">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 4 affected members of a consanguineous Pakistani family with brittle cornea syndrome-2 (BCS2; 614170), Burkitt Wright et al. (2011) identified homozygosity for a 52.46-kb in-frame deletion encompassing exons 9 through 14 of the PRDM5 gene, predicted to result in the loss of zinc fingers 6 through 13 of the protein. The deletion was not found in 454 control chromosomes, including 60 ethnically matched chromosomes. Family members who were heterozygous for the deletion had blue sclerae, small joint hypermobility, and corneal thickness that was more mildly reduced than that of homozygous individuals. Expression microarray analysis and quantitative PCR showed significant downregulation of genes encoding molecules involved in extracellular matrix development and maintenance, with a greater than 30-fold decrease in COL11A1 (120280), HAPLN1 (115435), and EDIL3 (606018), compared to controls.</Attribute>
              <Citation>
                <ID Source="PubMed">21664999</ID>
              </Citation>
              <XRef DB="OMIM" ID="614170" Type="MIM" />
              <XRef DB="OMIM" ID="120280" Type="MIM" />
              <XRef DB="OMIM" ID="115435" Type="MIM" />
              <XRef DB="OMIM" ID="606018" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Using dermal fibroblasts from 2 affected cousins from the Pakistani family previously studied by Burkitt Wright et al. (2011), Porter et al. (2015) performed expression microarray analysis and found enrichment for genes implicated in blood vessel development and maintenance. The authors noted that 30% of upregulated and 34% of downregulated PRDM5-bound genes were ECM components, and suggested that PRDM5 directly targets ECM genes involved in blood vessel biology, consistent with the retinal capillary morphologic abnormalities seen in the patients' eyes. In addition, expression of HP1BP3 (616072) was significantly decreased in retinal tissue from the 2 patients compared to a control retina, and there was enrichment for H3K9me1/2 at upregulated ECM-related genes in patient fibroblasts, suggesting a role for H3K9-interacting proteins in PRDM5-associated disease.</Attribute>
              <Citation>
                <ID Source="PubMed">21664999</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">26395458</ID>
              </Citation>
              <XRef DB="OMIM" ID="616072" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRDM5" />
          </GeneList>
          <Name>PRDM5, 52.46-KB DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">52.46-KB DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="614161.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">BRITTLE CORNEA SYNDROME 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="50653" TraitType="Disease" MappingType="Name" MappingValue="BRITTLE CORNEA SYNDROME 2" MappingRef="Preferred">
        <MedGen CUI="C3280011" Name="Brittle cornea syndrome 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

